Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅱa Clinical Study to Evaluate the Efficacy and Safety of YN001 in Patients With Coronary Atherosclerosis in Australia

NCT06700720 is registered in ClinicalTrials.gov with Beijing Inno Medicine Co., Ltd. as lead sponsor.

NCT NCT06700720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅱa Clinical Study to Evaluate the Efficacy and Safety of YN001 in Patients With Coronary Atherosclerosis in Australia
Lead sponsor
Beijing Inno Medicine Co., Ltd.
Phase
Phase 2
Overall status
Terminated
Start date
February 25, 2026
Completion date
July 22, 2026
Enrollment
3 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary atherosclerotic disease